Section
Deals
M&A, licensing, and major transactions shaping the industry
DealsPharmaceutical Technology ↗
Boehringer Ingelheim and Zai Lab have entered into a clinical collaboration to investigate a dual DLL3-targeti…
DealsBioPharma Dive ↗
Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimen…
DealsEndpoints News ↗
Inside Biogen's $5.6B buyout: CEO Chris Viehbacher has carried on with diversifying Biogen's business beyond i…
← Newer
Page 11
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.